Close

Analyst Ratings for Century Therapeutics (IPSC) [Buys]

IPSC Rating Summary

IPSC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IPSC
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.60 (+317.2%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/5/2023 EF Hutton Tony Butler New Coverage Buy
(N/A)
18.00
(N/A)
4.97
(3.26)
-34.41% Details
12/27/2022 Chardan Capital Markets
» Updated 8/9/2023
Geulah Livshits New Coverage Buy
(N/A)
17.00
(19.00)
5.67
(3.26)
-42.5% Details